Edwards PASCAL経カテーテル弁修復システムの重要な臨床試験 (CLASP II TR)
Edwards PASCAL 経カテーテル弁修復システムと最適な医療療法 (OMT) を用いた経カテーテル三尖弁修復の安全性と有効性を、三尖弁逆流患者における OMT 単独と比較して評価するための前向き多施設無作為化対照ピボタル試験
To establish the safety and effectiveness of the Edwards PASCAL Transcatheter Repair System in patients with symptomatic severe tricuspid regurgitation who have been determined to be at an intermediate or greater estimated risk of mortality with tricuspid valve surgery by the cardiac surgeon with concurrence by the local Heart Team
調査の概要
状態
状態
条件
条件
介入・治療
介入・治療
詳細な説明
A Prospective, multicenter, randomized, controlled pivotal trial to evaluate the safety and effectiveness of transcatheter tricuspid valve repair with the Edwards PASCAL Transcatheter Valve Repair System and optimal medical therapy (OMT) compared to OMT alone in patients with tricuspid regurgitation. Patients will be seen for follow-up visits at discharge, 30 days, 3 months, 6 months, and annually through 5 years.
研究の種類
研究の種類
入学 (推定)
入学
段階
段階
- 適用できない
連絡先と場所
研究場所
-
-
Arizona
-
Phoenix、Arizona、アメリカ、85006
- Banner University Medical Center Phoenix
-
Tucson、Arizona、アメリカ、85712
- Tucson Medical Center Healthcare
-
-
California
-
Irvine、California、アメリカ、92868
- University of California, Irvine
-
La Jolla、California、アメリカ、92037
- SCPMG - Kaiser San Diego
-
Los Angeles、California、アメリカ、90048
- Cedars Sinai Medical Center
-
Los Angeles、California、アメリカ、90095
- UCLA Medical Center
-
San Francisco、California、アメリカ、94143
- University of California, San Francisco
-
San Francisco、California、アメリカ、94118
- Kaiser Permanente San Francisco
-
Stanford、California、アメリカ、94305
- Stanford University
-
-
Colorado
-
Denver、Colorado、アメリカ、80218
- St. Joseph Hospital
-
Loveland、Colorado、アメリカ、80538
- Medical Center of the Rockies
-
-
Florida
-
Gainesville、Florida、アメリカ、32605
- The Cardiac and Vascular Institute Research Foundation
-
Miami Beach、Florida、アメリカ、33140
- Mount Sinai Medical Center
-
Naples、Florida、アメリカ、34102
- NCH Healthcare System
-
Sarasota、Florida、アメリカ、34239
- Sarasota Memorial Health Care System
-
Tallahassee、Florida、アメリカ、32308
- Tallahassee Research Institute
-
-
Georgia
-
Atlanta、Georgia、アメリカ、30309
- Piedmont Healthcare, Inc.
-
Atlanta、Georgia、アメリカ、30308
- Emory University Hospital Midtown / Emory University - St. Joseph's Hospital
-
-
Illinois
-
Chicago、Illinois、アメリカ、60611
- Northwestern University
-
-
Indiana
-
Indianapolis、Indiana、アメリカ、46290
- Ascension St. Vincent Heart Center Cardiovascular Research Institute
-
-
Iowa
-
Iowa City、Iowa、アメリカ、52242
- University of Iowa Hospitals & Clinics
-
-
Louisiana
-
New Orleans、Louisiana、アメリカ、70121
- Ochsner Medical Center
-
-
Maryland
-
Baltimore、Maryland、アメリカ、21287
- Johns Hopkins
-
-
Massachusetts
-
Boston、Massachusetts、アメリカ、02114
- Massachusetts General Hospital
-
-
Michigan
-
Ann Arbor、Michigan、アメリカ、48109
- University of Michigan
-
Detroit、Michigan、アメリカ、48202
- Henry Ford Hospital
-
Royal Oak、Michigan、アメリカ、48073
- William Beaumont Hospital - Royal Oak
-
Saginaw、Michigan、アメリカ、48601
- St. Mary's of Ascension Research
-
-
Minnesota
-
Maplewood、Minnesota、アメリカ、55109
- Fairview Health Services
-
Rochester、Minnesota、アメリカ、55905
- Mayo Clinic
-
-
Missouri
-
Kansas City、Missouri、アメリカ、64111
- Saint Luke's Hospital of Kansas City
-
St Louis、Missouri、アメリカ、63110
- Washington University School of Medicine
-
-
Montana
-
Missoula、Montana、アメリカ、59802
- Providence St. Patrick Hospital
-
-
New Hampshire
-
Lebanon、New Hampshire、アメリカ、03756
- Dartmouth-Hitchcock Medical Center
-
-
New Jersey
-
Camden、New Jersey、アメリカ、09103
- Cooper Health Systems
-
Morristown、New Jersey、アメリカ、07962
- Morristown Medical Center
-
New Brunswick、New Jersey、アメリカ、08901
- Rutgers Robert Wood Johnson Medical School
-
-
New York
-
Buffalo、New York、アメリカ、14203
- State University of New York at Buffalo
-
New York、New York、アメリカ、10065
- Weill Cornell Medicine
-
New York、New York、アメリカ、10032
- Columbia University Irving Medical Center/NYPH
-
New York、New York、アメリカ、10075
- Lenox Hill Hospital, Northwell Health /Northshore University Hospital Manhasset
-
Rochester、New York、アメリカ、14621
- Rochester General Hospital
-
Roslyn、New York、アメリカ、11576
- St. Francis Hospital
-
The Bronx、New York、アメリカ、10467
- Montefiore Medical Center / Arts Pavilion / Hutchinson Metro Center Clinic / Weiler Hospital / Moses Hospital
-
-
North Carolina
-
Chapel Hill、North Carolina、アメリカ、27517
- University of North Carolina
-
-
North Dakota
-
Fargo、North Dakota、アメリカ、58104
- Sanford Medical Center Fargo
-
-
Ohio
-
Cincinnati、Ohio、アメリカ、45219
- The Christ Hospital
-
Cincinnati、Ohio、アメリカ、45242
- TriHealth-Bethesda North Hospital
-
Columbus、Ohio、アメリカ、43210
- The Ohio State University
-
-
Oklahoma
-
Oklahoma City、Oklahoma、アメリカ、73112
- Integris Baptist Medical Center
-
Oklahoma City、Oklahoma、アメリカ、73120
- Oklahoma Cardiovascular Research Group
-
Tulsa、Oklahoma、アメリカ、74104
- Oklahoma Heart Institute at Hillcrest Medical Center
-
-
Oregon
-
Portland、Oregon、アメリカ、97239
- Oregon Health & Science University
-
-
Pennsylvania
-
Hershey、Pennsylvania、アメリカ、17033
- Penn State Hershey
-
Philadelphia、Pennsylvania、アメリカ、19104
- Pennsylvania Presbyterian Medical Center / Hospital of the University of Pennsylvania
-
Wormleysburg、Pennsylvania、アメリカ、17043
- Pinnacle Health Cardiovascular Institute/UPMC Pinnacle
-
Wynnewood、Pennsylvania、アメリカ、19096
- Lankenau Heart Institute
-
-
South Carolina
-
Charleston、South Carolina、アメリカ、29245
- Medical University of South Carolina
-
-
Tennessee
-
Chattanooga、Tennessee、アメリカ、37403
- Erlanger Health System
-
Nashville、Tennessee、アメリカ、37212
- Vanderbilt University Medical Center
-
-
Texas
-
Houston、Texas、アメリカ、77030
- The University of Texas Health Science Center at Houston
-
Houston、Texas、アメリカ、77004
- HCA Houston Healthcare Medical Center
-
Houston、Texas、アメリカ、77030
- Baylor College of Medicine St. Luke's Medical Center
-
Houston、Texas、アメリカ、77030
- UTHealth/Memorial Hermann Hospital
-
Plano、Texas、アメリカ、75093
- Baylor Scott & White - The Heart Hospital - Plano
-
-
Utah
-
Murray、Utah、アメリカ、84107
- Intermountain Medical Center
-
St. George、Utah、アメリカ、84790
- St. George Regional Hospital
-
-
Virginia
-
Charlottesville、Virginia、アメリカ、22908
- University of Virginia Health System
-
Richmond、Virginia、アメリカ、23298
- Virginia Commonwealth University
-
Roanoke、Virginia、アメリカ、24014
- Carilion Medical Center
-
-
Washington
-
Seattle、Washington、アメリカ、98101
- Virginia Mason Medical Center
-
Seattle、Washington、アメリカ、98122
- Swedish Medical Center
-
-
Wisconsin
-
Milwaukee、Wisconsin、アメリカ、53226
- Medical College of Wisconsin
-
-
-
-
British Columbia
-
Vancouver、British Columbia、カナダ、V6Z 1Y6
- St. Paul's Hospital
-
-
Ontario
-
Hamilton、Ontario、カナダ、L8L 2X2
- Hamilton Health Services
-
Ottawa、Ontario、カナダ、K1Y 4Q7
- University of Ottawa Heart Institute
-
Toronto、Ontario、カナダ、M4N 3M5
- Sunnybrook Health Sciences Centre
-
Toronto、Ontario、カナダ、M5B 1W8
- St. Michael's Hospital
-
-
Quebec
-
Québec、Quebec、カナダ、G1V 4G5
- Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval
-
-
参加基準
適格基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Eighteen (18) years of age or older
- Despite medical therapy, per the local Heart Team, patient has signs of TR, symptoms from TR, or prior heart failure hospitalization from TR.
- Severe or greater tricuspid regurgitation
- New York Heart Association (NYHA) Class II-IVa or heart failure hospitalization in the prior 12 months
- Patient is at an intermediate or greater estimated risk of mortality with tricuspid valve surgery as determined by the cardiac surgeon with concurrence by the local Heart Team
- Patient is able and willing to give informed consent, follow protocol procedures, and comply with follow-up visit requirements
Exclusion Criteria:
-
Tricuspid valve anatomy not evaluable by TTE or TEE
-
Tricuspid valve anatomy precludes proper device deployment and function
-
Patient with refractory heart failure requiring, advanced intervention (i.e. patient has or will need left ventricular assist device, or transplantation) (ACC/AHA Stage D heart failure)
-
Presence of trans-tricuspid pacemaker or defibrillator leads which meet one of the following:
- Would prevent proper TR reduction due to interaction of the lead with the leaflets
- Were implanted in the RV within the last 90 days prior to the point of enrollment
-
Primary non-degenerative tricuspid disease
-
Previous tricuspid valve repair or replacement that would interfere with placement of PASCAL
-
Clinically significant, untreated coronary artery disease requiring revascularization, unstable angina, evidence of acute coronary syndrome, recent myocardial infarction
-
Significant intra-cardiac mass, thrombus, or vegetation per echo core lab assessment
-
Deep vein thrombosis (DVT) or pulmonary embolism (PE) in the last 90 days
-
Recent Stroke
-
Active gastrointestinal (GI) bleeding
-
Presence of infiltrative cardiomyopathy or valvulopathy (including carcinoid, amyloidosis, sarcoidosis, hemochromatosis) or significant congenital heart disease, including but not limited to atrial septal defect, RV dysplasia, and arrhythmogenic RV
-
Need for emergent or urgent surgery for any reason, any planned cardiac surgery within the next 12 months (365 days), or any planned percutaneous cardiac procedure within the next 90 days
-
Any of the following cardiovascular procedures:
- Percutaneous coronary, intracardiac, or endovascular intervention within the last 30 days prior to the point of enrollment
- Carotid surgery within 30 days prior to the point of enrollment
- Direct current cardioversion within the last 30 days prior to the point of enrollment
- Leadless RV pacemaker implant within the last 30 days prior to the point of enrollment
- Cardiac surgery within 90 days prior to the point of enrollment
-
Severe aortic, mitral and/or pulmonic valve stenosis and/or regurgitation
-
Known history of untreated severe symptomatic carotid stenosis or asymptomatic carotid stenosis
-
Active endocarditis within the last 90 days or infection requiring antibiotic therapy within the last 14 days
-
Patient is oxygen-dependent or requires continuous home oxygen
-
Pregnant, breastfeeding, or planning pregnancy within the next 12 months (365 days)
-
Concurrent medical condition with a life expectancy of less than 12 months in the judgment of the Investigator
-
Patient is currently participating in another investigational biologic, drug, or device clinical study
-
Patient has other medical, social, or psychological conditions that preclude appropriate consent and follow-up, or the patient is under guardianship
-
Any patient considered to be vulnerable
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
アーム数
武器と介入
参加者グループ / アーム参加者グループ / アーム |
介入・治療介入・治療 |
|---|---|
|
実験的:Edwards PASCAL System & OMT
Transcatheter tricuspid valve repair with the Edwards PASCAL system in patients on optimal medical therapy (OMT) with tricuspid regurgitation |
Transcatheter tricuspid valve repair with the Edwards PASCAL System in patients on optimal medical therapy
他の名前:
Transcatheter tricuspid valve repair with the Edwards PASCAL System in conjunction with OMT Transcatheter tricuspid valve repair with the Edwards PASCAL system in patients on optimal medical therapy (OMT) with tricuspid regurgitation |
|
アクティブコンパレータ:Optimal Medical Therapy (OMT)
Optimal medical therapy (OMT) alone in patients with tricuspid regurgitation |
Optimal Medical Therapy alone in patients with tricuspid regurgitation |
|
実験的:Single-Arm Registry
Transcatheter tricuspid valve repair with the Edwards PASCAL System in conjunction with optimal medical therapy (OMT) in patients with tricuspid regurgitation who are not eligible for randomization |
Transcatheter tricuspid valve repair with the Edwards PASCAL System in patients on optimal medical therapy
他の名前:
Transcatheter tricuspid valve repair with the Edwards PASCAL System in conjunction with OMT Transcatheter tricuspid valve repair with the Edwards PASCAL system in patients on optimal medical therapy (OMT) with tricuspid regurgitation |
|
実験的:Continued Access Study
Transcatheter tricuspid valve repair with the Edwards PASCAL system in patients on optimal medical therapy (OMT) with tricuspid regurgitation |
Transcatheter tricuspid valve repair with the Edwards PASCAL System in patients on optimal medical therapy
他の名前:
Transcatheter tricuspid valve repair with the Edwards PASCAL System in conjunction with OMT Transcatheter tricuspid valve repair with the Edwards PASCAL system in patients on optimal medical therapy (OMT) with tricuspid regurgitation |
この研究は何を測定していますか?
主要な結果の測定
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Composite endpoint including all-cause mortality, RVAD implantation or heart transplant, tricuspid valve intervention, heart failure hospitalizations, and Quality of Life improvement (measured by KCCQ score)
時間枠:6 months
|
Comparison of number of participants with composite endpoint events between experimental and active comparator arms |
6 months
|
二次結果の測定
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
1 Grade Reduction in TR Severity
時間枠:6, 12 months
|
Total number of participants with at least 1 grade reduction in TR severity |
6, 12 months
|
|
Quality of Life (QOL) as Measured by the Kansas City Cardiomyopathy Questionnaire (KCCQ)
時間枠:3, 6, and 12 months
|
Change in KCCQ score from baseline |
3, 6, and 12 months
|
|
All Cause Mortality
時間枠:12 months, 24 months
|
Total number of deaths from any cause |
12 months, 24 months
|
|
Death and Heart Failure Hospitalizations
時間枠:12 months
|
Total number of deaths and hospital admissions due to heart failure |
12 months
|
|
All-cause Mortality, TV Surgery or TV Interventions
時間枠:24 months
|
Total number of deaths, TV surgeries or interventions |
24 months
|
|
Right ventricular end-diastolic diameter (RVEDD mid)
時間枠:12 months
|
Change in right ventricular end-diastolic diameter (RVEDD mid) |
12 months
|
|
Major Adverse Events (MAEs)
時間枠:30 days
|
Overall rate of Major Adverse Events (MAEs) |
30 days
|
|
Reduction in TR grade
時間枠:Intraprocedural post-implantation
|
Reduction in TR severity as assessed by TEE pre- and post-implantation |
Intraprocedural post-implantation
|
|
All-Cause Mortality
時間枠:12 months, annually through 5 years
|
Total number of deaths from any cause |
12 months, annually through 5 years
|
|
Heart failure hospitalizations
時間枠:12 months, annually through 5 years
|
Total number of hospital admissions due to heart failure |
12 months, annually through 5 years
|
|
Non-elective tricuspid valve re-intervenitions (percutaneous or surgical)
時間枠:12 months, annually through 5 years
|
Total number of non-elective tricuspid valve re-interventions |
12 months, annually through 5 years
|
|
Durable RVAD implantation or heart transplant
時間枠:12 months, annually through 5 years
|
Total number of patients requiring RVAD impantantion or heart transplant |
12 months, annually through 5 years
|
|
Need for paracentesis
時間枠:12 months, annually through 5 years
|
Total nunber of patients who required paracentesis |
12 months, annually through 5 years
|
|
All cause mortality or the first heart failure hospitalization for patients with massive or torrential TR at baseline
時間枠:12, 24 months
|
Time to death or first heart failure hospitalization |
12, 24 months
|
|
All-cause Hospitalizations
時間枠:12 months
|
Number of hospitalizations for any cause |
12 months
|
協力者と研究者
捜査官
捜査官
- 主任研究者:Martin B. Leon, MD、Columbia University
- 主任研究者:Michael J. Mack, MD、Baylor Scott and White Health
- スタディチェア:Gorav Ailawadi, MD、University of Michigan
- 主任研究者:Charles Davidson, MD、Northwestern University
- スタディチェア:Allen Anderson, MD、The University of Texas Health Science Center at San Antonio
出版物と役立つリンク
研究記録日
主要日程の研究
研究開始 (実際)
研究開始
一次修了 (推定)
一次修了
研究の完了 (推定)
研究の完了
試験登録日
最初に提出
最初に提出
QC基準を満たした最初の提出物
QC基準を満たした最初の提出物
最初の投稿 (実際)
最初の投稿
学習記録の更新
投稿された最後の更新 (実際)
投稿された最後の更新
QC基準を満たした最後の更新が送信されました
QC基準を満たした最後の更新が送信されました
最終確認日
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。